Clinical Trial Update: Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and tolerability of CS10BR05 Injection in individuals with Multiple System Atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• CS10BR05 Injection

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Multiple System Atrophy | Phase 1 | Status: COMPLETED